These results demonstrate a selective overexpression of TfR1 in glioma cells and prompt the use of The-05 protein for the selective delivery to tumor cells of the non-camptothecin topoisomerase I inhibitor, Genz-644282. Here, TFRC is linked to central nervous system cancer.